Product complaint # (b)(4).The device catalog number is unknown; therefore, udi is unavailable.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
This complaint is from a literature source.The following literature cite has been reviewed: yang l, lin z, jianping x, et al.Population with hypercoagulant condition during total knee replacement control studies with hemostatic bands.Chinese journal of joint surgery (electronic edition), august 2018, 12(4):495-500.Objective and methods: the purpose of this article was to explore the postoperative effect of different hemostatic bands on perioperative blood production in a population of 92 patients with hypercoagulation status during total knee replacement.Inclusion criteria were patients with a plasma d-dimer higher than 1000 jig/l ¿ a value that exceeded more than one time of the upper limit of the normal value.In patients with hypercoagulant status, higher d-dimer levels in plasma suggest a higher likelihood of vascular-related complications.All patients received a pfc sigma pr tka.There is insufficient information to determine the manufacturer of the cement utilized in the procedure or if the patellas were resurfaced.46 patients only had tourniquet only during the cementation process and 46 had a tourniquet applied from incision to wound closure.Lot, model and catalog number are not available, but the suspected depuy device possibly associated with reported adverse events: pfc sigma rp construct including femoral component, tibial insert, and tibial tray adverse event(s) and provided interventions associated with depuy devices: 22 patient received postoperative blood transfusions 7 postoperative asymptomatic dvt- 6 treated conservatively and 1 treated with embolectomy 21 intramuscular or small vein thrombi- treated with oral anticoagulants and venous pumps 1 femoral thrombosis with associated swelling.
|